m6a/IGF2BP3-Driven Serine Biosynthesis Fuels AML Stemness and Metabolic Vulnerability

0
1541
Researchers identified RNA N6-methyladenosine (m6A) modification as a key regulator of serine biosynthesis in acute myeloid leukemia.
[Nature Communications]
Full Article